88 related articles for article (PubMed ID: 35779264)
1. SparseSignatures: An R package using LASSO-regularized non-negative matrix factorization to identify mutational signatures from human tumor samples.
Mella L; Lal A; Angaroni F; Maspero D; Piazza R; Sidow A; Antoniotti M; Graudenzi A; Ramazzotti D
STAR Protoc; 2022 Sep; 3(3):101513. PubMed ID: 35779264
[TBL] [Abstract][Full Text] [Related]
2. De novo mutational signature discovery in tumor genomes using SparseSignatures.
Lal A; Liu K; Tibshirani R; Sidow A; Ramazzotti D
PLoS Comput Biol; 2021 Jun; 17(6):e1009119. PubMed ID: 34181655
[TBL] [Abstract][Full Text] [Related]
3. Model selection and robust inference of mutational signatures using Negative Binomial non-negative matrix factorization.
Pelizzola M; Laursen R; Hobolth A
BMC Bioinformatics; 2023 May; 24(1):187. PubMed ID: 37158829
[TBL] [Abstract][Full Text] [Related]
4. Flexible model-based non-negative matrix factorization with application to mutational signatures.
Laursen R; Maretty L; Hobolth A
Stat Appl Genet Mol Biol; 2024 Jan; 23(1):. PubMed ID: 38753402
[TBL] [Abstract][Full Text] [Related]
5. Protocol to benchmark gene expression signature scoring techniques for single-cell RNA sequencing data in cancer.
Noureen N; Wang X; Zheng S
STAR Protoc; 2022 Dec; 3(4):101877. PubMed ID: 36595948
[TBL] [Abstract][Full Text] [Related]
6. Deep Unfolding for Non-Negative Matrix Factorization with Application to Mutational Signature Analysis.
Nasser R; Eldar YC; Sharan R
J Comput Biol; 2022 Jan; 29(1):45-55. PubMed ID: 34986029
[TBL] [Abstract][Full Text] [Related]
7. MutSignatures: an R package for extraction and analysis of cancer mutational signatures.
Fantini D; Vidimar V; Yu Y; Condello S; Meeks JJ
Sci Rep; 2020 Oct; 10(1):18217. PubMed ID: 33106540
[TBL] [Abstract][Full Text] [Related]
8. Mutational signature learning with supervised negative binomial non-negative matrix factorization.
Lyu X; Garret J; Rätsch G; Lehmann KV
Bioinformatics; 2020 Jul; 36(Suppl_1):i154-i160. PubMed ID: 32657388
[TBL] [Abstract][Full Text] [Related]
9. Relating mutational signature exposures to clinical data in cancers via signeR 2.0.
Drummond RD; Defelicibus A; Meyenberg M; Valieris R; Dias-Neto E; Rosales RA; da Silva IT
BMC Bioinformatics; 2023 Nov; 24(1):439. PubMed ID: 37990302
[TBL] [Abstract][Full Text] [Related]
10. MutVis: Automated framework for analysis and visualization of mutational signatures in pathogenic bacterial strains.
Prasanna A; Niranjan V
Infect Genet Evol; 2021 Jul; 91():104805. PubMed ID: 33689914
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome sequencing and mutational analysis of human cord-blood derived stem and progenitor cells.
Rosendahl Huber A; van Leeuwen AJCN; Peci F; de Kanter JK; Bertrums EJM; van Boxtel R
STAR Protoc; 2022 Jun; 3(2):101361. PubMed ID: 35573477
[TBL] [Abstract][Full Text] [Related]
12. Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline.
Sienkiewicz K; Ratan A
STAR Protoc; 2022 Mar; 3(1):101110. PubMed ID: 35106500
[TBL] [Abstract][Full Text] [Related]
13. signeR: an empirical Bayesian approach to mutational signature discovery.
Rosales RA; Drummond RD; Valieris R; Dias-Neto E; da Silva IT
Bioinformatics; 2017 Jan; 33(1):8-16. PubMed ID: 27591080
[TBL] [Abstract][Full Text] [Related]
14. A Simple Model-Based Approach to Inferring and Visualizing Cancer Mutation Signatures.
Shiraishi Y; Tremmel G; Miyano S; Stephens M
PLoS Genet; 2015 Dec; 11(12):e1005657. PubMed ID: 26630308
[TBL] [Abstract][Full Text] [Related]
15. Protocol for comparing gene-level selection on coding mutations between two groups of samples with Coselens.
Iranzo J; Gruenhagen G; Calle-Espinosa J; Koonin EV
STAR Protoc; 2023 Mar; 4(1):102117. PubMed ID: 36853661
[TBL] [Abstract][Full Text] [Related]
16. mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies.
Rustad EH; Nadeu F; Angelopoulos N; Ziccheddu B; Bolli N; Puente XS; Campo E; Landgren O; Maura F
Commun Biol; 2021 Mar; 4(1):424. PubMed ID: 33782531
[TBL] [Abstract][Full Text] [Related]
17. decompTumor2Sig: identification of mutational signatures active in individual tumors.
Krüger S; Piro RM
BMC Bioinformatics; 2019 Apr; 20(Suppl 4):152. PubMed ID: 30999866
[TBL] [Abstract][Full Text] [Related]
18. A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.
Li XC; Wang MY; Yang M; Dai HJ; Zhang BF; Wang W; Chu XL; Wang X; Zheng H; Niu RF; Zhang W; Chen KX
Ann Oncol; 2018 Apr; 29(4):938-944. PubMed ID: 29351612
[TBL] [Abstract][Full Text] [Related]
19. SigsPack, a package for cancer mutational signatures.
Schumann F; Blanc E; Messerschmidt C; Blankenstein T; Busse A; Beule D
BMC Bioinformatics; 2019 Sep; 20(1):450. PubMed ID: 31477009
[TBL] [Abstract][Full Text] [Related]
20. scQUEST: Quantifying tumor ecosystem heterogeneity from mass or flow cytometry data.
Martinelli AL; Wagner J; Bodenmiller B; Rapsomaniki MA
STAR Protoc; 2022 Sep; 3(3):101578. PubMed ID: 35880127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
